Logo
84767

Image Credit:84767

Which Dose of Acetaminophen is Safe in Cirrhotic Patients?

Author(s):
Hassan SoleimanpourHassan SoleimanpourHassan Soleimanpour ORCID1, Zahra  ParsianZahra ParsianZahra  Parsian ORCID2, Kavous  Shahsavari NiaKavous Shahsavari NiaKavous  Shahsavari Nia ORCID3, Farzad  RahmaniFarzad Rahmani3, Seyed Moayed AlavianSeyed Moayed AlavianSeyed Moayed Alavian ORCID4, 5,*
1Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
2Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
5Tehran Hepatitis Center, Tehran, Iran


Hepatitis Monthly:Vol. 19, issue 5; e84767
Published online:May 28, 2019
Article type:Letter
Received:Sep 29, 2018
Accepted:May 12, 2019
How to Cite:Hassan SoleimanpourZahra ParsianKavous Shahsavari NiaFarzad RahmaniSeyed Moayed AlavianWhich Dose of Acetaminophen is Safe in Cirrhotic Patients?.Hepat Mon.19(5):e84767.https://doi.org/10.5812/hepatmon.84767.

Dear Editor,

Pain management is crucial in all patients. Three main drug categories that control pain are opiates, non-steroidal anti-inflammatory drugs (NSAIDs), and acetaminophen. Opiates can cause sedation and constipation; they may also predispose cirrhotic patients to hepatic encephalopathy, so they are not favored in cirrhotic patients (1). NSAIDs increase the risk of gastrointestinal bleeding and renal injury, additively they decrease diuretics’ efficacy in cirrhotic patients (2). A well-known fact that acetaminophen is metabolized in liver and liver impairment ensues from acetaminophen overdose, creats an assumption that acetaminophen is not safe in these patients (1). The aim of this letter was to discuss the safe dose of acetaminophen in cirrhotic patients.

Acetaminophen at dose of 1 gram per day, for periods as short as 5 days does not even alter the half-life of acetaminophen in patients with hepatic failure (3). It might be necessary to reduce the dose in patients with liver disease especially those who are malnourished or underweight (4). Some studies that have evaluated the safe dose of acetaminophen in cirrhotic patients concluded that acetaminophen 2 grams per day is safe, and does not correlate with hepatic decompensation (5). This dose is found safe even for long term administration (1). Admittedly, this dose is not considered toxic in patients who have decompensated liver cirrhosis (6). Patients with alcoholic cirrhosis can also take up to 3 grams of acetaminophen each day (7). Doses as high as 4 grams per day taken for more than 5 days have not shown any toxic effects in patients with chronic liver disease (8). When this dose is administered to those with stable cirrhosis, its safety has been shown even for 13 days (9). It can thus be concluded that, acetaminophen is safe in cirrhotic patients at a dose of 2 - 3 grams per day for long term; and for short duration even 4 grams can be administered safely.

Footnotes

References

  • 1.
    Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: A literature review and evidence-based recommendations. Hepat Mon. 2014;14(10). e23539. [PubMed ID: 25477978]. [PubMed Central ID: PMC4250965]. https://doi.org/10.5812/hepatmon.23539.
  • 2.
    Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, et al. The role of non-steroidal anti-inflammatory drugs (NSAIDS) in the treatment of patients with hepatic disease: A review article. Anesth Pain Med. 2016;6(4). e37822. [PubMed ID: 27843779]. [PubMed Central ID: PMC5100664]. https://doi.org/10.5812/aapm.37822.
  • 3.
    Andreasen PB, Hutters L. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver. Acta Med Scand Suppl. 1979;624:99-105. [PubMed ID: 284720].
  • 4.
    Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81(2):210-22. [PubMed ID: 26460177]. [PubMed Central ID: PMC4833155]. https://doi.org/10.1111/bcp.12802.
  • 5.
    Riley TR, Smith JP. Preventive care in chronic liver disease. J Gen Intern Med. 1999;14(11):699-704. [PubMed ID: 10571719]. [PubMed Central ID: PMC1496761]. https://doi.org/10.1046/j.1525-1497.1999.11188.x.
  • 6.
    Lewis JH, Stine JG. Review article: Prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther. 2013;37(12):1132-56. [PubMed ID: 23638982]. https://doi.org/10.1111/apt.12324.
  • 7.
    Lucena MI, Andrade RJ, Tognoni G, Hidalgo R, Sanchez de la Cuesta F; Spanish Collaborative Study Group on Therapeutic Management of Liver Diseases. Drug use for non-hepatic associated conditions in patients with liver cirrhosis. Eur J Clin Pharmacol. 2003;59(1):71-6. [PubMed ID: 12684727]. https://doi.org/10.1007/s00228-003-0586-2.
  • 8.
    Hirschfield GM, Kumagi T, Heathcote EJ. Preventative hepatology: Minimising symptoms and optimising care. Liver Int. 2008;28(7):922-34. [PubMed ID: 18783540]. https://doi.org/10.1111/j.1478-3231.2008.01816.x.
  • 9.
    Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther. 1983;33(1):95-101. [PubMed ID: 6848304]. https://doi.org/10.1038/clpt.1983.14.
comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles